T1	Participants 55 84	experimental human influenza:
T2	Participants 153 182	Influenza virus neuraminidase
T3	Participants 494 575	prevention and the early treatment of influenza in experimentally infected humans
T4	Participants 584 676	Two randomized, double-blind, placebo-controlled trials conducted between June and July 1997
T5	Participants 762 919	A total of 117 healthy adult volunteers (aged 18-40 years; median age, 21 years) who were susceptible (hemagglutination-inhibition antibody titer < or =1:8).
T6	Participants 934 1017	All subjects were inoculated intranasally with influenza A/Texas/36/91 (H1N1) virus
T7	Participants 2923 2984	antiviral and clinical effects in experimental human influenz
